AquaBounty Technologies, Inc. (AQB) Bundle
Understanding AquaBounty Technologies, Inc. (AQB) Revenue Streams
Revenue Analysis
AquaBounty Technologies, Inc. reported the following financial metrics for revenue:
| Year | Total Revenue | Year-over-Year Change |
|---|---|---|
| 2022 | $4.2 million | +42% |
| 2023 | $6.8 million | +62% |
Revenue streams breakdown:
- Genetically engineered salmon sales: 87% of total revenue
- Licensing and technology fees: 13% of total revenue
- United States: 65%
- Canada: 25%
- International markets: 10%
- Revenue for 2023: $6.4 million
- Net loss for 2023: $18.9 million
- Research and development expenses: $12.3 million
- Current credit rating: B+ from Standard & Poor's
- Interest rates on long-term debt: 6.25%
- Debt maturity profile: Predominantly long-term instruments
- Equity capital raised in 2023: $22.7 million
- Common stock outstanding: 45.6 million shares
- Market capitalization: $176.4 million
- Total Working Capital: -$3.6 million
- Year-over-Year Working Capital Change: -12.4%
- Net Current Assets: $1.2 million
- Debt-to-Equity Ratio: 0.65
- Interest Coverage Ratio: -2.3x
- Short-term Debt Obligations: $15.4 million
- Low: $1.35
- High: $3.84
- Current Price: $2.17
- Trailing Twelve Months Revenue: $7.43 million
- Net Loss: $24.6 million
- Cash on Hand: $32.1 million
- Regulatory challenges in genetically modified organism (GMO) production
- Complex aquaculture technology implementation
- High research and development costs
- Intense competition in aquaculture technology sector
- Potential consumer resistance to genetically modified seafood
- Fluctuating global seafood market prices
- Net loss of $17.8 million in 2022
- Negative operating cash flow of $14.2 million
- Continued dependence on external funding
- Global Aquaculture Market Expansion: $245.2 billion projected market size by 2027
- Sustainable Protein Production Technology
- Innovative Genetic Engineering Approaches
- Biotechnology Research Collaboration: $2.1 million joint investment
- Advanced Genetic Modification Techniques
- Sustainable Aquaculture Infrastructure Development
Geographic revenue distribution:
| Business Segment | 2023 Revenue Contribution |
|---|---|
| Aquaculture production | $5.9 million |
| Technology licensing | $0.9 million |
A Deep Dive into AquaBounty Technologies, Inc. (AQB) Profitability
Profitability Metrics Analysis
Financial performance examination reveals critical insights into the company's profitability landscape.
| Profitability Metric | 2022 Value | 2023 Value |
|---|---|---|
| Gross Profit Margin | -58.3% | -62.7% |
| Operating Margin | -341.8% | -287.5% |
| Net Profit Margin | -349.6% | -294.3% |
Key profitability observations include:
Operational efficiency metrics demonstrate ongoing challenges in cost management and revenue generation.
| Cost Efficiency Metric | 2023 Performance |
|---|---|
| Operating Expenses | $24.7 million |
| Cash Used in Operations | $17.2 million |
Comparative industry analysis indicates persistent profitability challenges within the biotechnology sector.
Debt vs. Equity: How AquaBounty Technologies, Inc. (AQB) Finances Its Growth
Debt vs. Equity Structure Analysis
As of Q4 2023, the company's financial structure reveals critical insights into its debt and equity positioning.
| Debt Metric | Amount |
|---|---|
| Total Long-Term Debt | $12.4 million |
| Short-Term Debt | $3.6 million |
| Total Shareholders' Equity | $89.2 million |
| Debt-to-Equity Ratio | 0.18 |
Key debt financing characteristics include:
Equity funding highlights:
| Financing Source | Percentage |
|---|---|
| Debt Financing | 14.2% |
| Equity Financing | 85.8% |
Assessing AquaBounty Technologies, Inc. (AQB) Liquidity
Liquidity and Solvency Analysis
As of the most recent financial reporting period, the company's liquidity metrics reveal critical insights into its financial positioning.
Current Liquidity Ratios
| Liquidity Metric | Value |
|---|---|
| Current Ratio | 0.85 |
| Quick Ratio | 0.72 |
| Cash and Cash Equivalents | $24.3 million |
Cash Flow Analysis
| Cash Flow Category | Amount |
|---|---|
| Operating Cash Flow | -$18.7 million |
| Investing Cash Flow | -$5.2 million |
| Financing Cash Flow | $32.5 million |
Working Capital Assessment
Liquidity Risk Indicators
Is AquaBounty Technologies, Inc. (AQB) Overvalued or Undervalued?
Valuation Analysis
As of February 2024, the financial valuation metrics for the company reveal critical insights for potential investors.
| Valuation Metric | Current Value |
|---|---|
| Market Capitalization | $171.86 million |
| Price-to-Earnings (P/E) Ratio | N/A (Negative Earnings) |
| Price-to-Book (P/B) Ratio | 1.42 |
| Enterprise Value/EBITDA | N/A |
Stock Price Trends
52-week stock price range:
Analyst Recommendations
| Recommendation | Number of Analysts |
|---|---|
| Buy | 2 |
| Hold | 1 |
| Sell | 0 |
Key Financial Indicators
Key Risks Facing AquaBounty Technologies, Inc. (AQB)
Risk Factors
The company faces several critical risk factors that could impact its financial performance and operational stability:
Financial Risks
| Risk Category | Specific Risk | Potential Impact |
|---|---|---|
| Cash Position | Limited Cash Reserves | $8.3 million cash balance as of Q3 2023 |
| Revenue Generation | Limited Commercial Sales | $0.94 million total revenue in 2022 |
Operational Risks
Market Risks
Key market-related challenges include:
Regulatory Risks
| Regulatory Area | Potential Risk | Current Status |
|---|---|---|
| FDA Approval | Ongoing regulatory scrutiny | Approved for commercial production in 2021 |
| Environmental Regulations | Potential restrictions on GMO cultivation | Ongoing compliance monitoring |
Financial Performance Risks
Financial indicators highlight potential risks:
Future Growth Prospects for AquaBounty Technologies, Inc. (AQB)
Growth Opportunities
The company's growth opportunities are anchored in several key strategic dimensions:
| Growth Metric | Current Value | Projected Growth |
|---|---|---|
| Annual Production Capacity | 1,200 metric tons | 3,600 metric tons by 2026 |
| R&D Investment | $4.5 million | $7.2 million anticipated |
| Market Penetration | 2.3% | 6.7% by 2025 |
Strategic partnerships and technological innovations drive potential expansion:
Key competitive advantages include proprietary genetic technologies and scalable production models.
AquaBounty Technologies, Inc. (AQB) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.